Journal News

Do sperm offer the uterus
a secret handshake?

Researchers discover endometrial receptor that can recognize surface molecule
Laurel Oldach
January 22, 2020

Why does it take 200 million sperm to fertilize a single egg?

One reason: When sperm arrive in the uterus, they are bombarded by the immune system. Perhaps, molecular anthropologist Pascal Gagneux says, many are needed so some will survive. On the other hand, the female may benefit by culling so many sperm.

“I’m a lonely zoologist in a medical school,” Gagneux said. “My elevator spiel is that all of life is one big compromise. (For an egg), being too easy to fertilize is bad; being too difficult to fertilize is also bad.”

Gagneux’s lab at the University of California, San Diego, has discovered the makings of something that might be compared to a secret handshake between sperm and the cells lining the uterus in mice and, perhaps, humans. Uterine cells, they report in the Journal of Biological Chemistry, express a receptor that recognizes a glycan molecule on the surface of sperm cells. This interaction might adjust the female’s immune response and help sperm make it through the leukocytic reaction. 

JBC-news-sperm-leukocytic-resposne-(1).jpg
Tecle et al. JBC 2019
An artistic rendering (not to scale) shows how the “secret handshake” between sperm and endometrial cells takes place. The surface of sperm is coated in glycans, branched structures that are rich in sialic acid. These can be recognized by sialic acid binding receptors, called siglecs, found on the surface of endometrial cells.

The leukocytic reaction is not well understood. What we do know, Gagneux said, is that “after crossing the cervix, millions of sperm — a U.S. population worth of sperm — that arrive in the uterus are faced by a barrage of macrophages and neutrophils.” 

This attack by the innate immune system kills most of the sperm cells in semen, winnowing hundreds of millions down to just a few hundred that enter the fallopian tubes. The defensive response may help prevent polyspermy, when an egg is fertilized by more than one sperm and cannot develop.

Sperm are coated in sialic acid–rich glycans, and the innate immune system uses sialic acid to differentiate human cells from invaders, so Gagneux and his lab expected that the glycan might interact with innate immune cells called neutrophils. But human neutrophils they tested were activated to a similar degree by sperm with and without sialic acid.

Meanwhile, the team noticed sialic acid–binding receptors called siglecs on endometrial cells. In solution, these endometrial receptors can bind to whole sperm. According to Gagneux, the binding interaction might help the sperm run the gantlet of the leukocytic response — for example, by dampening the immune response. Alternatively, it may be a way for uterine cells to weed out faulty sperm. In the immune system, siglecs help cells to recognize sialic acid molecules as markers of the body’s own cells, and in that context they can turn inflammation either up or down.

“It’s somewhat embarrassing how little we can say about what this (interaction) means,” Gagneux said. To understand its physiological significance, researchers first must look for direct interaction between sperm and intact uterine tissue — this paper looked at only sperm interacting with purified proteins and isolated cells. 

It’s humbling to work in such a poorly understood area, Gagneux said. Reproduction “is a very, very delicate tug-of-war at many levels. The fact that there is (also) this immune game going on is completely fascinating.”

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Progeria: From the unknown to the first FDA-approved treatment
Health Observance

Progeria: From the unknown to the first FDA-approved treatment

February 25, 2021

Hutchinson–Gilford progeria syndrome is a rare, fatal genetic disease that causes premature aging.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.

A novel approach to septic shock leads to a prospective new therapy
Journal News

A novel approach to septic shock leads to a prospective new therapy

February 23, 2021

A French research team finds new evidence supporting endotoxin removal for treating life-threatening inflammation.

When scientists become allergic to their research
News

When scientists become allergic to their research

February 21, 2021

Researchers spend long periods of time around the organisms they study. Sometimes, that exposure has unintended effects.

In mice, a mother's love comes from the gut
News

In mice, a mother's love comes from the gut

February 20, 2021

Scientists from the Salk Institute report a new influence on maternal behavior arising from an unexpected source.